Who is sponsoring NCT03607864?

NCT03607864 is sponsored by Cairo University.

What drugs are being tested in NCT03607864?

Interventions in NCT03607864: coral bone graft and xenograft.

What condition does NCT03607864 study?

NCT03607864 studies Badly Decayed Anterior Maxillary Teeth.

Is NCT03607864 still recruiting?

NCT03607864 is currently terminated. Last updated 21 July 2020.

Last reviewed 2020-07-21 · How we verify

NCT03607864

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Coral Bone Graft Verses Xenograft With Immediate Implant in Maxillary Anterior Esthetic Zone

Terminated NA Last updated 21 July 2020

What this trial tests

NA trial testing coral bone graft and xenograft in Badly Decayed Anterior Maxillary Teeth in 18 participants. Terminated before completion.

Timeline

10 June 2019

Primary endpoint
10 June 2020

10 June 2020

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	18
Start date	10 June 2019
Primary completion	10 June 2020
Estimated completion	10 June 2020
Sites	1 location across Egypt

Drugs / interventions tested

coral bone graft and xenograft

Conditions studied

Badly Decayed Anterior Maxillary Teeth — all drugs for Badly Decayed Anterior Maxillary Teeth →

Sponsor

Cairo University

Who can join

Adults 25 to 60, any sex, with Badly Decayed Anterior Maxillary Teeth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Autogenous bone graft is considered to be the golden standard for grafting as it has osteoconductive , osteoinductive and osteogenic functions , however it has the problems of donor site morbidity , the need for two surgeries as well as post operative swelling and discomfort of the patient , so alternative bone grafts as alloplast has been introduced. Coral bone has a structure which is similar to that of cancellous bone , its mechanical properties is similar to that of bone and it consists of high content of calcium carbonate scaffolds that has the advantages of being biodegradable , biocompatible and osteoconductive , they act as a carrier for growth factors and allow cell attachment , growth , spreading , differentiation and has been found to be effective bone graft

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03607864 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 21 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03607864.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing